Massive allograft bone is the primary source of bone graft material for use in limb salvage procedures after oncological tumor resection. However, allograft bone has been found to incorporate slowly into host bone resulting in allograft susceptibility to non-union, fracture, infection and fatigue failure. Clinical studies have shown that massive allograft bone has a 50% to 75% success rate at 10 years [1].

This content is only available via PDF.
You do not currently have access to this content.